>
Neo-onco-vascularisation, neoangio-onco-genesis and oncocapillars screening
Neo-onco-vascularisation, neoangio-onco-genesis and oncocapillars screening
Neo-onco-vascularisation, neoangio-onco-genesis and oncocapillars screening
Neo-onco-vascularisation, neoangio-onco-genesis and oncocapillars screening
Neo-onco-vascularisation, neoangio-onco-genesis and oncocapillars screening

Neo-onco-vascularisation, neoangio-onco-genesis and oncocapillars screening

Center for Technology transfer "Veritas"

Regular price €4,870.00 Sale

Oncocapillaries - as prediction of a tumour

This sub-technology “Oncocapillaries” is based on the Vascular Screening Technology and has observed early features of pathological neovascularization at the microcirculation level.

Ukrainian scientists have approved (http://angio-veritas.com/projects/oncocapillaries/?lang=en), that:

  • pathological reconstructions in capillaries are the pre-conditions for a development of the tumour process in 1-5 years prior to the clinical picture of oncological diseases.
  • vascular stage of angio-onco-genesis is very sensitive to correction and able to protect the development of a tumour in the locus.
  • Preclinical screening of an oncopathology is a technology that provides screening, diagnostics, monitoring of the oncodisease development and tracing correctness of treatment tactics. 
  • Reduce the numbers of pathological capillaries shows the successful cases for recovering from oncodisease and long term positive catamnesis.

Thus, vascular screening is obliquus for oncoscreening at the early stages of tumour process.

Diagnostic and monitoring of neo-onco-vascularization can check up, appear and monitoring the oncoprocess and it’s possible to manage this process at the evidential medicine base.

 

Potential consumers

  • Medical establishments of primary link of medical care; 
  • Specialized medical establishments of oncoprofile; 
  • Family doctors

 

Advantages

  • High-fidelity; 
  • Bloodless; 
  • Painless; 
  • Safe; 
  • Absent contra-indications; 
  • Diagnostics last 5-10 minutes;
  • Reliable and logical; 
  • Dynamics of the process is controlled by a patient and doctor
  • Visualization of picture and analytical histogram is understandable for everybody

 

Competitors

  • Oncotest – screening quantitate test, which is based on metabolic changes; 
  • Computed tomography and MRT – visualization of a tumour and main vessels; 
  • Biopsy – invasive and uses for verification of malignisation process.

 

It is a humane break-even technology!

It is a socially responsible business!